Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

First lupus drug in half a century approved

Nature (2011)Cite this article

Subjects

A therapeutic antibody is the first success in a wave of experimental therapies aimed at tackling the autoimmune disease.

For more than 50 years, the autoimmune disease lupus has confounded drug developers. But a new therapy finally broke through that barrier yesterday when the US Food and Drug Administration (FDA) announced the approval of Benlysta (belimumab) for the treatment of systemic lupus erythematosus.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Nature Reviews Drug Discovery correspondence: Genomics drugs in clinical trials

Nature Reviews Rheumatology

Related external links

NIH lupus factsheet

Human Genome Sciences

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ledford, H. First lupus drug in half a century approved. Nature (2011). https://doi.org/10.1038/news.2011.150

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2011.150

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing